White House officials on Tuesday shot down a report speculating that President Trump gained access to the retatrutide weight-loss drug under the Food and Drug Administration’s (FDA) “compassionate use program.
Source: [The Hill](https://thehill.com/homenews/administration/5937098-white-house-denies-trump-retatrutide/)